IP Library Assignment 017027/0113
Patent Assignment
Reel/Frame 017027/0113

Assignment of Assignor's Interest

Recorded: 2005-11-16 Pages: 7
Assignors
LAMPH, WILLIAM W.
Executed: 2004-10-28
BISCHOF, ERIC D.
Executed: 2004-10-13
HEYMAN, RICHARD A.
Executed: 2004-10-13
Assignee
LIGAND PHARMACEUTICALS INCORPORATED
10275 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Methods and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using Rxr Modulators
Patent: 7,259,188 →
Application: 10/229,649 →
Publication: US 2003/0013766
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the the Assignor's Name from Bischof, Eric D. to Bischoff, Eric D. Previously Recorded on Reel 017027 Frame 0113. Assignor(S) Hereby Confirms the Assignment of Assignors Interest (See Document for Details). Jul 17, 2007
From: LAMPH, WILLIAM W.; BISCHOFF, ERIC D.; HEYMAN, RICHARD A.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 019567/0490 →
Assignment of Assignor's Interest Aug 6, 2008
From: LIGAND PHARMACEUTICALS INCORPORATED; SERAGEN, INC.
To: EISAI INC.
Reel/Frame 021339/0344 →